Retour au classement

CorVel Corp. (CRVL)

NEUTRAL
Financial ServicesInsurance BrokersUnited States

Fondamental

66

Prix

$69.80

Capitalisation boursière

$3.61B

Partie 1 · Ce que vaut l'entreprise

Vue d'ensemble

CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Bilan & Liquidités

Chiffre d'affaires

$984M

12 derniers mois (au 30/06/2026)

Résultat net

$115M

12 derniers mois (au 30/06/2026)

Flux de trésorerie libre

$110M

Capitaux propres totaux

$394M

Passif total

$249M

Ratio de liquidité général

1.94

Couverture des intérêts

-

Dette/EBITDA

0.15

Bénéfice par action

Chiffre d'affaires & Résultat net

Flux de trésorerie libre

Décomposition du résultat

État historique

Marges dans le temps

La dette dans le temps

Le poids de la dette

Grille de la croissance

Croissance — Chiffre d'affaires

Estimation de la juste valeur

General caseSurévalué

Juste valeur

$26.35

Prix actuel

$69.80

Marge de sécurité

-164.9%

Fourchette de juste valeur

$21.89 - $30.80

Méthodes d'estimation

Analyst price target:Not enough data to compute it
Discounted cash flow (DCF):$27.68
Earnings multiple (P/E):$29.87
Graham growth formula:$16.83
Earnings power value (EPV):$21.27
Justified P/B:$27.00
Dividend discount (Gordon):Not enough data to compute it
P/FFO, funds from operations:Not enough data to compute it
Mid-cycle earnings:Not enough data to compute it
Revenue multiple:Not enough data to compute it

Indicateurs de valorisation

Ratio P/E

31.66

ROE

28.0%

Ratio P/B

8.80

P/FCF

31.61

Marge brute

24.8%

ROIC

-

Radar de rentabilité

Value Creation (Economic Moat)

ROIC

-

WACC

10.3%

ROIC − WACC

-

Critères d'analyse fondamentale

Réussi (14)

  • EPS shows upward trend
  • Price CAGR 19.12%
  • Debt/Equity ratio
  • Positive Free Cash Flow
  • Current Ratio
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • ROE 29.9%
  • Revenue Growth 5Y 11.6%
  • Earnings Quality (OCF/NI) 1.31
  • Share Dilution -0.8%
  • Net Margin Trend 11.7% vs 11.0%
  • Piotroski F-Score 7/9

Échoué (7)

  • EPS CAGR 0.24%
  • Gross Margin 24.8%
  • P/FCF 31.61
  • P/B Ratio 8.80
  • CapEx intensity
  • Price below Graham Number
  • DCF valuation (Overvalued)

Indisponible (7)

  • ROIC NaN%
  • Dividend Payout NaN%
  • Operating Margin NaN%
  • Interest Coverage
  • Analyst Consensus (Finnhub)
  • Earnings Surprise (no valid data)
  • PEG Ratio (need PE > 0 and growth > 0)

Score F de Piotroski

7/9

Santé financière solide

score
criteria

Qualité des bénéfices

1.31

Qualité élevée : bénéfices soutenus par la trésorerie

Dilution du capital

-0.8%

Rachat d'actions. Favorable aux actionnaires

Gouvernance

Équipe dirigeante

NomTitreÂge
Mr. Michael G. CombsExecutive Chair61
Mr. Brian S. NicholsChief Financial Officer44
Ms. Jennifer L. YossVice President of Accounting47
Mr. Maxim ShishinChief Information Officer50
Mr. Mark E. BertelsExecutive Vice President of Risk Management Services62
Ms. Sarah ScottPresident & CEO48
Ms. Sharon F. O'ConnorVice President of Legal Services-
Melissa StoranVice President of Marketing-
Jason WheelerVice President of Sales & Account Management-
Mr. Jeffrey D. GurtcheffChief Claims Officer-

Risque d'audit

4

Risque du conseil

6

Risque de rémunération

5

Risque droits des actionnaires

7

Partie 2 · Le prix et le moment d'entrer

Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.

Latest News

Recent headlines for CRVL, sourced from Markets Gazette.

No recent news for CRVL.